Shanghai Haohai Biological Technology Co., Ltd. has appointed Tang Minjie as Chief Financial Officer.
Tang, aged 41, joined the company in August 2016 as an employee and became a director of Shenzhen New Industries Material of Ophthalmology Co., Ltd., a non-wholly owned subsidiary of the company, since 15 November 2016.
Prior to joining the company, he worked at Ernst and Young during the period from August 1998 to July 2016 and most recently served as an audit partner from July 2010 to July 2016.
Tang obtained a bachelor degree in economics from the former international business school of the University of Shanghai in July 1998, and was qualified as a certified public accountant in the People’s Republic of China in June 2000 and CPA in the United States in June 2006.
